Aveanna Healthcare Holdings Inc. (AVAH)
NASDAQ (NGS) NASDAQ (NGS) Primary 
Should Value Investors Buy Aveanna Healthcare (AVAH) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
How Much Upside is Left in Aveanna (AVAH)? Wall Street Analysts Think 43.07%
The mean of analysts' price targets for Aveanna (AVAH) points to a 43.1% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Aveanna Healthcare Holdings: Recent Results Have Me More Optimistic (Rating Upgrade)
Aveanna Healthcare Holdings (AVAH) is upgraded to Buy, reflecting improved profitability and resilient demand for home healthcare services. AVAH's Q4 2025 net income surged, but adjusted EPS was $0.17 due to one-time tax benefits and merger costs. FY 2026 revenue guidance of $2.54–$2.56 billion disappointed, while adjusted EBITDA guidance slightly exceeded consensus.
Aveanna Healthcare Holdings Inc. (AVAH) Q4 2025 Earnings Call Transcript
Aveanna Healthcare Holdings Inc. (AVAH) Q4 2025 Earnings Call Transcript
Aveanna (AVAH) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
Although the revenue and EPS for Aveanna (AVAH) give a sense of how its business performed in the quarter ended December 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Aveanna Healthcare (AVAH) Beats Q4 Earnings and Revenue Estimates
Aveanna Healthcare (AVAH) came out with quarterly earnings of $0.17 per share, beating the Zacks Consensus Estimate of $0.12 per share. This compares to earnings of $0.05 per share a year ago.
Gear Up for Aveanna (AVAH) Q4 Earnings: Wall Street Estimates for Key Metrics
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Aveanna (AVAH), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended December 2025.
Aveanna (AVAH) Upgraded to Strong Buy: What Does It Mean for the Stock?
Aveanna (AVAH) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
New Strong Buy Stocks for January 21st
BAYRY, DAKT, ZTO, LRLCY and AVAH have been added to the Zacks Rank #1 (Strong Buy) List on January 21, 2026.
Aveanna Healthcare Holdings Inc. (AVAH) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Aveanna Healthcare Holdings Inc. (AVAH) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Should Value Investors Buy Aveanna Healthcare (AVAH) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Are Investors Undervaluing Aveanna Healthcare (AVAH) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
